Summary of professional guidelines

As guidelines are identified that relate to a disorder, gene, or variant, staff at NCBI connect them to the appropriate records. This page provides an alphabetical list of the professional practice guidelines, position statements, and recommendations that have been identified. We welcome suggestions to add any we may have missed. 

You can also identify all conditions in MedGen associated with guidelines via this URL: https://www.ncbi.nlm.nih.gov/medgen?term="has%20guideline"[Properties]

  abbrev Title Date
1 AAN, 2014 Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Oct 14, 2014
2 AAN, 2012 Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology Aug 07, 2012
3 AAN/CNS, 2011 Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Oct 25, 2011
4 AAN/CNS, 2009 Practice Parameter: Evaluation of the child with microcephaly (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Sep 15, 2009
5 AAN/CNS, 2005 Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Jan 11, 2005
6 AAN/CNS, 2004 Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Mar 23, 2004
7 AAO, 2012 Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Nov 01, 2012
8 AAP, 2011 Health supervision for children with Down syndrome. Aug 01, 2011
9 AAP, 2011 Clinical report--health supervision for children with Prader-Willi syndrome. Jan 01, 2011
10 AAP, 2010 Noonan syndrome: clinical features, diagnosis, and management guidelines. Oct 01, 2010
11 AAP, 2005 Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Dec 01, 2005
12 AAP, 1996 Health supervision for children with Marfan syndrome. American Academy of Pediatrics Committee on Genetics. Nov 01, 1996
13 AASLD, 2011 Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases Jul 01, 2011
14 AASLD, 2008 Diagnosis and treatment of Wilson disease: an update. Jun 01, 2008
15 ACC/AHA, 2008 ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Dec 02, 2008
16 ACC/ESC, 2003 American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Nov 05, 2003
17 ACCF/AHA, 2010 ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Aug 03, 2010
18 ACCF/AHA, 2010 ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Jul 20, 2010
19 ACCP, 2013 Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. May 01, 2013
20 ACG, 2015 ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Feb 01, 2015
21 ACMG, 2016 Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Nov 17, 2016
22 ACMG, 2015 Don't order MTHFR genetic testing for the risk assessment of hereditary thrombophilia. Jul 10, 2015
23 ACMG, 2015 Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Mar 12, 2015
24 ACMG, 2015 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Mar 05, 2015
25 ACMG, 2015 ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Jan 01, 2015
26 ACMG, 2014 Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Nov 01, 2014
27 ACMG, 2014 American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss. Apr 01, 2014
28 ACMG, 2014 Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Feb 01, 2014
29 ACMG, 2014 Recommendations for the nutrition management of phenylalanine hydroxylase deficiency Feb 01, 2014
30 ACMG, 2014 ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Jan 01, 2014
31 ACMG, 2013 ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics. Jul 01, 2013
32 ACMG, 2013 ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Jun 20, 2013
33 ACMG, 2013 ACMG position statement on prenatal/preconception expanded carrier screening. Jun 01, 2013
34 ACMG, 2013 American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders. Jun 01, 2013
35 ACMG, 2013 ACMG statement on noninvasive prenatal screening for fetal aneuploidy. May 01, 2013
36 ACMG, 2013 Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. May 01, 2013
37 ACMG, 2013 ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Feb 01, 2013
38 ACMG, 2012 Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy. Dec 01, 2012
39 ACMG, 2012 Evaluation of the adolescent or adult with some features of Marfan syndrome. Jan 01, 2012
40 ACMG, 2010 Glycogen storage disease type III diagnosis and management guidelines. Jul 01, 2010
41 ACMG, 2009 Screening for fetal aneuploidy and neural tube defects. Nov 01, 2009
42 ACMG, 2009 ACMG practice guideline: Genetic evaluation of short stature Jun 01, 2009
43 ACMG, 2009 Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia Mar 01, 2009
44 ACMG, 2008 Carrier screening for spinal muscular atrophy Nov 01, 2008
45 ACMG, 2008 Clinical significance of tri-nucleotide repeats in Fragile X testing: A clarification of American College of Medical Genetics guidelines Nov 01, 2008
46 ACMG, 2008 Statement on guidance for genetic counseling in advanced paternal age Jun 01, 2008
47 ACMG, 2008 Clinical genetics evaluation in identifying the etiology of autism spectrum disorders Apr 01, 2008
48 ACMG, 2008 Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Feb 01, 2008
49 ACMG, 2008 Carrier screening in individuals of Ashkenazi Jewish descent Jan 01, 2008
50 ACMG, 2008 Carrier screening in individuals of Ashkenazi Jewish descent. Jan 01, 2008
51 ACMG, 2008 First trimester diagnosis and screening for fetal aneuploidy. Jan 01, 2008
52 ACMG, 2006 Genetic evaluation of suspected osteogenesis imperfecta (OI) Jun 01, 2006
53 ACMG, 2006 Executive Summary May 01, 2006
54 ACMG, 2006 Pompe disease diagnosis and management guideline May 01, 2006
55 ACMG, 2005 American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation. Nov 01, 2005
56 ACMG, 2005 Fragile X syndrome: Diagnostic and carrier testing Oct 01, 2005
57 ACMG, 2005 American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation Jan 01, 2005
58 ACMG, 2004 Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel Jan 01, 2004
59 ACMG, 2004 Technical standards and guidelines for Huntington disease testing. Jan 01, 2004
60 ACMG, 2002 Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss May 31, 2002
61 ACMG, 2001 American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Mar 01, 2001
62 ACMG, 2001 American College of Medical Genetics Statement on Diagnostic Testing for Uniparental Disomy Jan 01, 2001
63 ACMG, 2001 Technical Standards and Guidelines for Fragile X: The First of a Series of Disease-Specific Supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics Jan 01, 2001
64 ACMG ACT Sheet, 2011 American College of Medical Genetics ACT SHEET, Congenital Adrenal Hyperplasia, 2011 Jan 01, 2011
65 ACMG ACT Sheet, 2011 American College of Medical Genetics ACT SHEET, Congenital Hypothyroidism, 2011 Jan 01, 2011
66 ACMG ACT Sheet, 2010 American College of Medical Genetics ACT SHEET, Biotinidase Deficiency Jan 01, 2010
67 ACMG ACT Sheet, 2010 American College of Medical Genetics ACT SHEET, Congenital Hearing Loss, 2010 Jan 01, 2010
68 ACMG ACT Sheet, 2010 American College of Medical Genetics ACT SHEET, Hemoglobin S/Beta plus Thalassemia, 2010 Jan 01, 2010
69 ACMG ACT Sheet, 2010 American College of Medical Genetics ACT SHEET, Hemoglobin SC Disease, 2010 Jan 01, 2010
70 ACMG ACT Sheet, 2010 American College of Medical Genetics ACT SHEET, Sickle Cell Anemia, 2010 Jan 01, 2010
71 ACMG ACT Sheet, 2010 American College of Medical Genetics ACT SHEETs, Primary or Secondary Hypergalactosemia, 2010 Jan 01, 2010
72 ACMG ACT Sheets, 2010 ACMG ACT Sheets and Confirmatory Algorithms Jan 01, 2010
73 ACMG ACT Sheets, 2001 American College of Medical Genetics ACT SHEETs, Newborn Screening ACT Sheets and Confirmatory Algorithms Jan 01, 2001
74 ACMG Algorithm, 2009 American College of Medical Genetics Algorithm, Congenital Adrenal Hyperplasia, 2009 Jan 01, 2009
75 ACMG Algorithm, 2009 American College of Medical Genetics Algorithm, Congenital Hypothyroidism, 2009 Jan 01, 2009
76 ACMG Algorithm, 2009 American College of Medical Genetics Algorithm, Hb S Screening, 2009 Jan 01, 2009
77 ACMG Algorithm, 2009 American College of Medical Genetics Algorithm, Hearing Loss, 2009 Jan 01, 2009
78 ACMG Algorithm, 2009 American College of Medical Genetics Algorithm, Primary or Secondary Hypergalactosemia, 2009 Jan 01, 2009
79 ACMG Algorithm, 2006 American College of Medical Genetics Algorithm, Biotinidase Deficiency, 2006 Jan 01, 2006
80 ACMG Lab QA, 2002 Standards and guidelines for CFTR mutation testing. Sep 01, 2002
81 ACMG/ACOG, 2001 Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Mar 01, 2001
82 ACMG/ACOG/NSGC/PQF/SMFM, 2015 Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Mar 01, 2015
83 ACMG/ASHG, 1998 ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. May 01, 1998
84 ACMG/NSGC, 2015 A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Jan 01, 2015
85 ACMG/NSGC, 2011 Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Jun 01, 2011
86 ACOG, 2015 Committee opinion no. 616: Newborn screening and the role of the obstetrician-gynecologist. Jan 01, 2015
87 ACOG, 2012 ACOG committee opinion no. 527: Personalized genomic testing for disease risk. Jun 01, 2012
88 ACOG, 2011 Practice bulletin no. 124: inherited thrombophilias in pregnancy. Sep 01, 2011
89 ACOG, 2011 ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. Apr 01, 2011
90 ACOG, 2010 The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Jan 01, 2010
91 ACOG, 2009 ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Oct 01, 2009
92 ACOG, 2009 ACOG committee opinion No. 432: spinal muscular atrophy. May 01, 2009
93 ACOG, 2009 ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Apr 01, 2009
94 ACOG, 2007 ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Dec 01, 2007
95 ACOG, 2007 ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Jan 01, 2007
96 ACOG, 2007 ACOG technical bulletin. Hemoglobinopathies in pregnancy. Number 220--February 1996 (replaces no. 185, October 1993). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. May 01, 1996
97 ACP MPDG, 2014 RAS testing of colorectal carcinoma--a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group. Sep 01, 2014
98 ACR, 2012 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Oct 01, 2012
99 ACR, 2008 Ataxia. Aug 01, 2008
100 ACS, 2007 American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. Mar 01, 2007
101 AHA, 2013 Genetics and cardiovascular disease: a policy statement from the American Heart Association. Jul 03, 2012
102 AHA, 2004 Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Jun 08, 2004
103 AHA/ASA, 2014 Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Dec 01, 2014
104 AHRQ, 2013 Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death Jun 26, 2013
105 AHRQ, 2013 Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin Feb 20, 2013
106 AHRQ, 2012 Management of Asymptomatic Carotid Stenosis Aug 27, 2012
107 AHRQ, 2012 Measuring Health-Related Quality of Life for Patients with Diabetic Retinopathy Apr 23, 2012
108 AHRQ, 2010 Preventing Alzheimer's disease and cognitive decline. Apr 01, 2010
109 AHRQ, 201 Skin Substitutes for Treating Chronic Wounds Dec 18, 2012
110 AMP, 2013 Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology. Nov 01, 2013
111 AMP, 2012 Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. Nov 01, 2012
112 ASCO, 2014 Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline. Jul 01, 2014
113 ASCO, 2014 Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. Jul 01, 2014
114 ASCO, 2014 American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. Mar 10, 2014
115 ASCO, 2013 Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. Aug 10, 2013
116 ASCO, 2010 American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer Sep 01, 2010
117 ASCO, 2010 American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Feb 10, 2010
118 ASCO, 2009 American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment Feb 20, 2009
119 ASCO, 2007 American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Nov 20, 2007
120 ASCO, 2006 ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Nov 20, 2006
121 ASCO, 2003 American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Jun 15, 2003
122 ASCO/CAP, 2014 Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Feb 01, 2014
123 ASCO/CAP/IASLC/AMP, 2014 Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. Nov 10, 2014
124 ASCO/ESMO, 2015 Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. Jan 10, 2015
125 ASCRS, 2001 Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer--supporting documentation. Oct 01, 2001
126 ASHG/ACMG, 1995 Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents Nov 01, 1995
127 ATA, 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Jun 01, 2009
128 ATS, 2014 An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Nov 15, 2014
129 ATS, 2010 An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Mar 15, 2010
130 ATS/ERS, 2003 [American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. Jan 01, 2005
131 AUA, 2013 Early detection of prostate cancer: AUA Guideline. Aug 01, 2013
132 Brandi et al., 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. Dec 01, 2001
133 Brit Cmt Stand Hematol, 2010 Clinical guidelines for testing for heritable thrombophilia. Apr 01, 2010
134 Brit Cmt Stand Hematol/BTS, 2010 Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Jan 01, 2010
135 BSG, 2014 Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Aug 01, 2014
136 Caballero et al., 2012 International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. Feb 01, 2012
137 CAP/IASLC/AMP, 2013 Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Jul 01, 2013
138 CAPS, 2013 International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer Mar 01, 2013
139 CCCDTD, 2014 Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians. May 01, 2014
140 CCS, 2014 Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Jun 01, 2014
141 CDC, 2012 Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. Apr 06, 2012
142 CDC DMD Care Considerations Working Group, 2010 Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Feb 01, 2010
143 CDC DMD Care Considerations Working Group, 2010 Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Jan 01, 2010
144 CDC Respiratory Panel, 2010 The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article. Aug 01, 2010
145 CFF, 2009 Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. Dec 01, 2009
146 CFF, 2009 Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. Dec 01, 2009
147 Cochat et al., 2012 Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. May 01, 2012
148 CPGPT/CF FPT Committees, 2010 Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Aug 01, 2010
149 CPIC, 2017 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Apr 06, 2017
150 CPIC, 2016 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy. Dec 16, 2016
151 CPIC, 2015 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. Nov 09, 2015
152 CPIC, 2015 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. May 13, 2015
153 CPIC, 2015 Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Mar 18, 2015
154 CPIC, 2014 The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Oct 01, 2014
155 CPIC, 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing. Aug 06, 2014
156 CPIC, 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype. Jun 11, 2014
157 CPIC, 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype Mar 26, 2014
158 CPIC, 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update. Feb 21, 2014
159 CPIC, 2014 Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update. Jan 23, 2014
160 CPIC, 2013 Clinical pharmacogenetics implementation consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Dec 01, 2013
161 CPIC, 2013 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-a-Based Regimens. Oct 04, 2013
162 CPIC, 2013 Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Sep 01, 2013
163 CPIC, 2013 Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy May 22, 2013
164 CPIC, 2013 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing. May 21, 2013
165 CPIC, 2013 Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. May 01, 2013
166 CPIC, 2013 Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update Apr 01, 2013
167 CPIC, 2012 Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Feb 01, 2013
168 CPIC, 2012 The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy Jul 01, 2012
169 CPIC, 2012 Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing Apr 01, 2012
170 CPIC, 2012 Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype Feb 01, 2012
171 CPIC, 2011 Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing Oct 01, 2011
172 CPIC, 2011 Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing Mar 01, 2011
173 CPNDS, 2015 Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy. Aug 01, 2015
174 CPNDS, 2014 Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Apr 01, 2014
175 CPNDS, 2013 Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy. Jan 01, 2013
176 CSANZ, 2007 Guidelines for the diagnosis and management of Marfan syndrome. Feb 01, 2007
177 DailyMed Drug Label, 2016 DailyMed Drug Label, ZELBORAF, 2016 Aug 09, 2016
178 DailyMed Drug Label, 2016 DailyMed Drug Label, TAFINLAR, 2016 Jun 16, 2016
179 DailyMed Drug Label, 2016 DailyMed Drug Label, THIORIDAZINE HYDROCHLORIDE, 2016 May 04, 2016
180 DailyMed Drug Label, 2016 DailyMed Drug Label, OLYSIO, 2016 May 01, 2016
181 DailyMed Drug Label, 2015 DailyMed Drug Label, SOFOSBUVIR, 2015 Aug 28, 2015
182 DailyMed Drug Label, 2015 DailyMed Drug Label, PERJETA, 2015 Jun 30, 2015
183 DailyMed Drug Label, 2015 DailyMed Drug Label, FLUVOXAMINE MALEATE, 2015 May 01, 2015
184 DailyMed Drug Label, 2015 DailyMed Drug Label, TRIMIPRAMINE MALEATE, 2015 May 01, 2015
185 DailyMed Drug Label, 2015 DailyMed Drug Label, VFEND, 2015 Apr 01, 2015
186 DailyMed Drug Label, 2015 DailyMed Drug Label, CARBAMAZEPINE, 2015 Mar 31, 2015
187 DailyMed Drug Label, 2012 DailyMed Drug Label, KALYDECO, 2012 Mar 31, 2015
188 DailyMed Drug Label, 2015 DailyMed Drug Label, PEGASYS, 2015 Mar 31, 2015
189 DailyMed Drug Label, 2015 DailyMed Drug Label, XELODA, 2015 Mar 31, 2015
190 DailyMed Drug Label, 2015 DailyMed Drug Label, ELITEK, 2015 Mar 01, 2015
191 DailyMed Drug Label, 2015 DailyMed Drug Label, DELSYM (DEXTROMETHORPHAN), 2015 Feb 28, 2015
192 DailyMed Drug Label, 2015 DailyMed Drug Label, ERBITUX, 2015 Feb 28, 2015
193 DailyMed Drug Label, 2015 DailyMed Drug Label, COPEGUS, 2015 Jan 31, 2015
194 DailyMed Drug Label, 2015 DailyMed Drug Label, PEGINTRON, 2015 Jan 31, 2015
195 DailyMed Drug Label, 2015 DailyMed Drug Label, CLOMIPRAMINE HYDROCHLORIDE, 2015 Jan 01, 2015
196 DailyMed Drug Label, 2014 DailyMed Drug Label, CLOZAPINE, 2014 Dec 31, 2014
197 DailyMed Drug Label, 2014 DailyMed Drug Label, IMIPRAMINE HYDROCHLORIDE, 2014 Dec 01, 2014
198 DailyMed Drug Label, 2014 DailyMed Drug Label, ESCITALOPRAM OXALATE, 2014 Nov 01, 2014
199 DailyMed Drug Label, 2014 DailyMed Drug Label, VERAPAMIL HYDROCHLORIDE, 2014 Nov 01, 2014
200 DailyMed Drug Label, 2014 DailyMed Drug Label, TACROLIMUS, 2014 Oct 01, 2014
201 DailyMed Drug Label, 2014 DailyMed Drug Label, CYCLOSPORINE, 2014 Sep 01, 2014
202 DailyMed Drug Label, 2014 DailyMed Drug Label, CELECOXIB, 2014 Aug 31, 2014
203 DailyMed Drug Label, 2014 DailyMed Drug Label, CITALOPRAM, 2014 Aug 01, 2014
204 DailyMed Drug Label, 2014 DailyMed Drug Label, NEXIUM, 2014 Jul 31, 2014
205 DailyMed Drug Label, 2014 DailyMed Drug Label, VICTRELIS, 2014 Jul 31, 2014
206 DailyMed Drug Label, 2014 DailyMed Drug Label, CODEINE SULFATE, 2014 Jun 17, 2014
207 DailyMed Drug Label, 2014 DailyMed Drug Label, HERCEPTIN- trastuzumab, 2014 Jun 01, 2014
208 DailyMed Drug Label, 2014 DailyMed Drug Label, SPRYCEL, 2014 May 31, 2014
209 DailyMed Drug Label, 2014 DailyMed Drug Label, TARCEVA, 2014 Apr 30, 2014
210 DailyMed Drug Label, 2014 DailyMed Drug Label, ABACAVIR SULFATE, 2014 Apr 01, 2014
211 DailyMed Drug Label, 2014 DailyMed Drug Label, CHLOROQUINE PHOSPHATE, 2014 Mar 31, 2014
212 DailyMed Drug Label, 2014 DailyMed Drug Label, DESIPRAMINE HYDROCHLORIDE, 2014 Jan 07, 2014
213 DailyMed Drug Label, 2014 DailyMed Drug Label, PAROXETINE, 2014 Jan 01, 2014
214 DailyMed Drug Label, 2013 DailyMed Drug Label (DROSPIRENONE AND ETHINYL ESTRADIOL), 2013 Dec 31, 2013
215 DailyMed Drug Label, 2013 DailyMed Drug Label, ZETIA, 2013 Sep 30, 2013
216 DailyMed Drug Label, 2013 DailyMed Drug Label, AMIKACIN, 2013 May 31, 2013
217 DailyMed Drug Label, 2013 DailyMed Drug Label, CARVEDILOL, 2013 May 31, 2013
218 DailyMed Drug Label, 2013 DailyMed Drug Label, STREPTOMYCIN, 2013 May 31, 2013
219 DailyMed Drug Label, 2013 DailyMed Drug Label, TOBRAMYCIN, 2013 May 31, 2013
220 DailyMed Drug Label, 2013 DailyMed Drug Label, SERTRALINE, 2013 May 01, 2013
221 DailyMed Drug Label, 2013 DailyMed Drug Label, TABLOID, 2013 Mar 31, 2013
222 DailyMed Drug Label, 2013 DailyMed Drug Label, MORPHINE SULFATE, 2013 Jan 31, 2013
223 DailyMed Drug Label, 2013 FLUOXETINE capsule HUMAN PRESCRIPTION DRUG LABEL Jan 04, 2013
224 DailyMed Drug Label, 2013 DailyMed Drug Label, ALIMTA- pemetrexed disodium, 2013 Jan 01, 2013
225 DailyMed Drug Label, 2012 FASLODEX (fulvestrant) injection, [AstraZeneca Pharmaceuticals LP], HUMAN PRESCRIPTION DRUG LABEL Nov 01, 2012
226 DailyMed Drug Label, 2012 DailyMed Drug Label, AMITRIPTYLINE HYDROCHLORIDE, 2012 Oct 31, 2012
227 DailyMed Drug Label, 2012 OLANZAPINE (olanzapine) tablet HUMAN PRESCRIPTION DRUG LABEL Sep 01, 2012
228 DailyMed Drug Label, 2012 DailyMed Drug Label, DOXEPIN HYDROCHLORIDE, 2012 Aug 31, 2012
229 DailyMed Drug Label, 2012 DailyMed Drug Label, GENTAMICIN, 2012 Aug 31, 2012
230 DailyMed Drug Label, 2012 DailyMed Drug Label, ADRUCIL, 2012 Aug 01, 2012
231 DailyMed Drug Label, 2012 DailyMed Drug Label, CEVIMELINE, 2012 Jul 31, 2012
232 DailyMed Drug Label, 2012 DailyMed Drug Label, KANAMYCIN, 2012 May 31, 2012
233 DailyMed Drug Label, 2012 DailyMed Drug Label, MYLERAN, 2012 Mar 31, 2012
234 DailyMed Drug Label, 2012 DailyMed Drug Label, ABACAVIR SULFATE, 2012 Jan 01, 2012
235 DailyMed Drug Label, 2012 DailyMed Drug Label, ABILIFY, 2012 Jan 01, 2012
236 DailyMed Drug Label, 2012 DailyMed Drug Label, ATORVASTATIN CALCIUM, 2012 Jan 01, 2012
237 DailyMed Drug Label, 2012 DailyMed Drug Label, CODEINE SULFATE, 2012 Jan 01, 2012
238 DailyMed Drug Label, 2011 DailyMed Drug Label, DAPSONE, 2011 Jul 31, 2011
239 DailyMed Drug Label, 2011 DailyMed Drug Label, DILANTIN, 2011 Jul 31, 2011
240 DailyMed Drug Label, 2011 DailyMed Drug Label, QUINIDINE SULFATE, 2011 Jun 30, 2011
241 DailyMed Drug Label, 2011 DailyMed Drug Label, DIAZEPAM, 2011 Apr 30, 2011
242 DailyMed Drug Label, 2011 DailyMed Drug Label, NORTRIPTYLINE HYDROCHLORIDE, 2011 Mar 31, 2011
243 DailyMed Drug Label, 2011 DailyMed Drug Label, ATOMOXETINE HYDROCHLORIDE, 2011 Jan 01, 2011
244 DailyMed Drug Label, 2010 DailyMed Drug Label, ALLOPURINOL, 2010 Jan 01, 2010
245 DailyMed Drug label, 2010 DailyMed Drug label, CONCERTA (methylphenidate hydrochloride) tablet, extended release, 2010 Jan 01, 2010
246 DailyMed Drug Label, 2010 DailyMed Drug Label, COUMADIN, 2010 Jan 01, 2010
247 DailyMed Drug Label, 2010 DailyMed Drug Label, TRISENOX, 2010 Jan 01, 2010
248 DailyMed Drug Label, 2009 DailyMed Drug Label, PLAVIX, 2009 Jan 01, 2009
249 DailyMed Drug Label, 2007 DailyMed Drug Label, simvastatin, 2007 Jan 01, 2007
250 DailyMed Drug Label, 2015 DailyMed Drug Label, ADDYI, 2015
251 DailyMed Drug Label, 2016 DailyMed Drug Label, AMIODARONE HCL, 2016
252 DailyMed Drug Label, 2017 DailyMed Drug Label, BRIVIACT, 2017
253 DailyMed Drug Label, 2014 DailyMed Drug Label, CERDELGA, 2014
254 DailyMed Drug Label, 2017 DailyMed Drug Label, CHLORPROPAMIDE, 2017
255 DailyMed Drug Label, 2017 DailyMed Drug Label, DEXILANT- dexlansoprazole capsule, delayed release, 2017
256 DailyMed Drug Label, 2017 DailyMed Drug Label, DICLOFENAC POTASSIUM, 2017
257 DailyMed Drug Label, 2017 DailyMed Drug Label, DM2, 2017
258 DailyMed Drug Label, 2017 DailyMed Drug Label, GLIMEPIRIDE, 2017
259 DailyMed Drug Label, 2017 DailyMed Drug Label, GLIPIZIDE, 2017
260 DailyMed Drug Label, 2016 DailyMed Drug Label, GLYBURIDE, 2016
261 DailyMed Drug Label, 2016 DailyMed Drug Label, LACOSAMIDE, 2016
262 DailyMed Drug Label, 2017 DailyMed Drug Label, LANSOPRAZOLE, 2017
263 DailyMed Drug Label, 2012 DailyMed Drug Label, MELOXICAM, 2012
264 DailyMed Drug Label, 2016 DailyMed Drug Label, METHADONE HYDROCHLORIDE, 2016
265 DailyMed Drug Label, 2016 DailyMed Drug Label, ONDANSETRON, 2016
266 DailyMed Drug Label, 2017 DailyMed Drug Label, ONFI, 2017
267 DailyMed Drug Label, 2016 DailyMed Drug Label, PANTOPRAZOLE SODIUM, 2016
268 DailyMed Drug Label, 2016 DailyMed Drug Label, PIOGLITAZONE HYDROCHLORIDE, 2016
269 DailyMed Drug Label, 2017 DailyMed Drug Label, REYATAZ- atazanavir capsule, gelatin coated, 2017
270 DailyMed Drug Label, 2009 DailyMed Drug Label, ROSIGLITAZONE MALEATE, 2009
271 DailyMed Drug Label, 2015 DailyMed Drug Label, SIROLIMUS, 2015
272 DailyMed Drug Label, 2009 DailyMed Drug Label, TOLBUTAMIDE, 2009
273 DailyMed Drug Label, 2018 DailyMed Drug Label, ZURAMPIC, 2018
274 DMD Management and Anesthesia - ACCP, 2007 American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Dec 01, 2007
275 Dror et al., 2011 Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Dec 01, 2011
276 Dutch Pharmacogenetics Working Group, 2011 Pharmacogenetics: from bench to byte--an update of guidelines. May 01, 2011
277 Dutch SCG, 2013 Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Jun 01, 2013
278 EALSC, 2007 Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Aug 01, 2007
279 EAS, 2014 Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Aug 21, 2014
280 EASAC/FEAM, 201 The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes. Jul 01, 2013
281 ECD Global Alliance, 2014 Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Jul 24, 2014
282 ECFS, 2010 Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. Sep 01, 2010
283 EFNS, 2011 EFNS guidelines on diagnosis and treatment of primary dystonias. Jan 01, 2011
284 EFNS, 2010 EFNS guidelines for the diagnosis and management of Alzheimer's disease. Oct 01, 2010
285 EFNS, 2010 EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias. May 01, 2010
286 EFNS, 2010 EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias. Feb 01, 2010
287 EFNS, 2005 EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Dec 01, 2005
288 EFNS/ENS, 2014 EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Apr 01, 2014
289 EGAPP, 2014 Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? Apr 01, 2014
290 EGAPP, 2013 Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Jul 01, 2013
291 EGAPP, 2013 Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk improve health outcomes? Mar 14, 2013
292 EGAPP, 2011 Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Jan 01, 2011
293 EGAPP, 2010 Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health. Dec 01, 2010
294 EGAPP, 2009 Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Jan 01, 2009
295 EGAPP, 2009 Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Jan 01, 2009
296 EGAPP, 2009 Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives Jan 01, 2009
297 EGAPP, 2007 Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors Dec 01, 2007
298 EGAPP, 2007 Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Dec 01, 2007
299 EGTM, 2014 Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Jun 01, 2014
300 EHDN, 2014 Diagnostic genetic testing for Huntington's disease. Feb 01, 2015
301 EHDN, 2013 Recommendations for the predictive genetic test in Huntington's disease. Mar 01, 2013
302 EMHG, 2018 European Malignant Hyperthermia Group Guidelines, Causative mutations Jan 18, 2018
303 EMQN, 2014 EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Apr 01, 2015
304 EMQN, 2015 EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Apr 01, 2015
305 EMQN, 2012 Guidelines for the genetic diagnosis of hereditary recurrent fevers Oct 01, 2012
306 EMQN, 2012 EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta Jan 01, 2012
307 EMQN, 2008 EMQN Best Practice Guidelines and Recommendations on Myotonic Dystrophy types 1 and 2 Oct 31, 2010
308 EMQN/CMGS, 2013 EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease. May 01, 2013
309 Eng et al., 2006 Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Sep 01, 2006
310 ES, 2014 Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. Jun 01, 2014
311 ES, 2013 Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Dec 01, 2013
312 ES, 2012 Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. Sep 01, 2012
313 ESC, 2014 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Nov 01, 2014
314 ESC, 2014 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Oct 14, 2014
315 ESCGS, 2010 Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline Sep 01, 2010
316 ESE, 2014 The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Oct 01, 2014
317 ESHG/ASHG, 2015 Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Mar 18, 2015
318 ESHG/P3G/HUGO/PHGF, 2015 Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Jan 28, 2015
319 ESMO, 2013 Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Oct 01, 2013
320 ESMO, 2013 Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Oct 01, 2013
321 ESMO, 2012 ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Oct 01, 2012
322 ESPU, 2009 Abstracts of the ESPU (European Society for Paediatric Urology) XXth Annual Congress. May 6-9, 2009. Amsterdam, The Netherlands. Apr 01, 2009
323 EUNENBS, 2014 A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document. Jan 01, 2014
324 FARF, 2008 Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 Jan 01, 2008
325 FDA, 2014 FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation. Oct 01, 2014
326 FDA, 2014 U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations. Jul 01, 2014
327 Feldman et al., 2015 Recommendations for the management of patients with familial hypercholesterolemia. Jan 01, 2015
328 Fung et al., 2015 Practical guidelines for managing adults with 22q11.2 deletion syndrome. Jan 08, 2015
329 Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors. Dec 01, 2012
330 GHTF, 2012 Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. Jan 01, 2012
331 Giugliani et al., 2014 Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America. Jun 01, 2014
332 GMDI/SERC, 2014 Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Jul 01, 2014
333 Gonzalez et al., 2013 BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Apr 01, 2013
334 Guay-Woodford et al., 2014 Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. Sep 01, 2014
335 Hentgen et al., 2013 Evidence-based recommendations for the practical management of Familial Mediterranean Fever. Dec 01, 2013
336 HFSA, 2010 HFSA 2010 Comprehensive Heart Failure Practice Guideline. Jun 01, 2010
337 HGS Australasia, 2014 Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis. Dec 01, 2014
338 HHT Foundation Int'l, 2011 International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Feb 01, 2011
339 I-CET, 2013 Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Dec 01, 2013
340 IARC, 2008 Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results Nov 01, 2008
341 IBFM, 2014 Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years. Oct 01, 2014
342 ICCI, 2006 Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Aug 01, 2006
343 ICFMM, 2013 Position Statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing. Apr 01, 2013
344 ICSCCMD, 2014 Diagnostic approach to the congenital muscular dystrophies. Apr 01, 2014
345 IGCLC, 2010 Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research Jul 01, 2010
346 IHA/WFN, 1994 Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Aug 01, 1994
347 IHA/WFN, 1994 International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Jul 01, 1994
348 Int'l 22q11.2 Del Syndrome Consortium, 2011 Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome Aug 01, 2011
349 Int'l FH Foundation, 2014 Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Feb 15, 2014
350 Int'l RET Mutation Consortium, 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. Nov 20, 1996
351 Int'l SCC for CMD, 2010 Consensus statement on standard of care for congenital muscular dystrophies. Dec 01, 2010
352 Int'l SCC for SMA, 2007 Consensus statement for standard of care in spinal muscular atrophy. Aug 01, 2007
353 IPMFH, 2004 Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Mar 01, 2004
354 ISCA, 2010 Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. May 14, 2010
355 ISPD, 2012 Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Jan 01, 2012
356 KCPSG, 2014 Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group. Feb 01, 2014
357 KCPSG, 2013 Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group. Apr 01, 2013
358 KCRNC, 2013 Canadian guideline on genetic screening for hereditary renal cell cancers. Sep 01, 2013
359 Klujit et al., 2012 Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Sep 01, 2012
360 Langer et al., 2012 Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening. Sep 04, 2012
361 LWPES/ESPE, 2006 Consensus statement on management of intersex disorders. Jun 01, 2006
362 Mallorca, 2008 Guidelines for the clinical management of familial adenomatous polyposis (FAP). May 01, 2008
363 Mallorca group, 2013 Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Jun 01, 2013
364 MMS, 2014 Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Dec 11, 2014
365 Mork et al., 2015 Lynch Syndrome: A Primer for Urologists and Panel Recommendations. Feb 21, 2015
366 MSTF, 2014 Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Aug 01, 2014
367 MSTF, 2014 Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Aug 01, 2014
368 NACB, 2010 National Academy of Clinical Biochemistry, Clinical practice considerations. In: Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice, 2010 Jan 01, 2010
369 NACB, 2008 National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Dec 01, 2008
370 NANETS, 2010 The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma & Medullary Thyroid Cancer Aug 01, 2010
371 NBSTRN, 2015 Parental permission for pilot newborn screening research: guidelines from the NBSTRN. Feb 01, 2014
372 NCCBP, 2015 Updated UK Recommendations for HER2 assessment in breast cancer. Feb 01, 2015
373 NCCN, 2014 Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. Sep 01, 2014
374 NCCN, 2014 National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines): Breast Cancer Version 3.2014. Mar 01, 2014
375 NCCN, 2014 National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Breast Cancer Feb 01, 2014
376 NCCN, 2013 National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian Jun 10, 2013
377 NHFA, 2012 INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia. Mar 01, 2012
378 NICE, 2013 DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat: information for the public Sep 19, 2013
379 NICE, 2012 Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma Jan 12, 2012
380 NICE, 2009 Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update) Mar 01, 2009
381 NICE, 2009 National Institute for Health and Clinical Excellence, Cochlear implants for children and adults with severe to profound deafness, 2009 Jan 01, 2009
382 NICE, 2008 Identification and management of familial hypercholesterolaemia Aug 01, 2008
383 NICE, 2008 National Institute for Health and Clinical Excellence, Identification and management of familial hypercholesterolaemia, 2008 Jan 01, 2008
384 NIH, 2009 Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop Oct 07, 2010
385 NLAEP, 2011 Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Jun 01, 2011
386 NSGC, 2014 Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors. Feb 01, 2014
387 NSGC, 2014 Newborn screening: education, consent, and the residual blood spot. The position of the national society of genetic counselors. Feb 01, 2014
388 NSGC, 2013 Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. Oct 01, 2013
389 NSGC, 2013 Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. Jun 01, 2013
390 NSGC, 2013 NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. Apr 01, 2013
391 NSGC, 2013 NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. Feb 01, 2013
392 NSGC, 2011 Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors. Oct 01, 2011
393 NSGC, 2007 Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors. Aug 01, 2007
394 NSGC, 2007 Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. Jun 01, 2007
395 NSGC, 2005 Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors. Feb 01, 2005
396 NSGC, 2004 Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors. Apr 01, 2004
397 NSGC, 2002 Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. Apr 01, 2002
398 NYMAC, 2014 Diagnostic Guidelines for Confirmation of Screen-Positive Newborn Screening Results Sep 01, 2014
399 OARAC. 2013 Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Feb 12, 2013
400 Orphanet, 2013 Orphanet, Central Diabetes Insipidus, 2013 May 31, 2013
401 Orphanet, 2013 Orphanet, Duchenne muscular dystrophy, 2013 May 31, 2013
402 Orphanet, 2013 Orphanet, Hemiplegic Migraine (HM), 2013 May 31, 2013
403 Orphanet, 2013 Orphanet Emergency Guidelines: Type IV Ehlers-Danlos Syndrome May 01, 2013
404 Orphanet, 2013 Orphanet, Autoimmune myasthenia, 2013 May 01, 2013
405 Orphanet, 2013 Orphanet, Classic Homocystinuria, 2013 May 01, 2013
406 Orphanet, 2013 Orphanet, Familial Mediterranean fever, 2013 May 01, 2013
407 Orphanet, 2013 Orphanet, Steinert myotonic dystrophy, 2013 May 01, 2013
408 Orphanet, 2013 Orphanet Emergency Guidelines: Malignant hyperthermia Mar 01, 2013
409 Orphanet, 2013 Orphanet, Nephrogenic Diabetes Insipidus, 2013 Jan 31, 2013
410 Orphanet, 2010 Orphanet, Alpha-1 antitrypsin deficiency, 2010 Jan 01, 2010
411 Orphanet, 2010 Orphanet, Type 1 autoimmune polyendocrinopathy, 2010 Jan 01, 2010
412 Orphanet, 2009 Orphanet, Non histamine-induced angioedema, 2009 Jan 01, 2009
413 Orphanet, 2008 Orphanet, Dravet syndrome, 2008 Aug 12, 2008
414 Orphanet, 2008 Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI) Jun 04, 2008
415 Orphanet, 2008 Orphanet, Paroxysmal Nocturnal Haemoglobinuria, 2008 Jan 01, 2008
416 Orphanet, 2007 Orphanet emergency guideline: Cutaneous porphyrias, 2007 Oct 07, 2007
417 Orphanet, 2007 Orphanet, Amyotrophic lateral sclerosis, 2007 Jun 21, 2007
418 Orphanet, 2007 Orphanet, Acute hepatic porphyria neuro-visceral crisis, 2007 Jan 01, 2007
419 Orphanet, 2007 Orphanet, Marfan Syndrome, 2007 Jan 01, 2007
420 Orphanet, 2007 Orphanet, Tuberous sclerosis, 2007 Jan 01, 2007
421 PharmGKB, 2011 Dutch Pharmacogenetics Working Group Guideline for sertraline and CYP2C19 Aug 10, 2011
422 PLEF, 2014 Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum. Mar 01, 2014
423 PLEF, 2013 Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. May 01, 2013
424 PLoS Currents, 2011 Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk Jan 01, 2001
425 SACHDNC, 2013 Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children. Mar 01, 2013
426 Salviati et al, 2010 Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy Jun 01, 2010
427 SEAP/SEOM, 2015 Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Apr 01, 2015
428 SEAP/SEOM, 2012 Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM). Oct 01, 2012
429 SFH, 2014 Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Dec 01, 2014
430 SGO, 2014 Endometrial cancer: a review and current management strategies: part I. Aug 01, 2014
431 SGO, 2014 Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer Mar 01, 2014
432 SHARE, 2015 Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Apr 01, 2015
433 Skirton et al., 2014 Offering prenatal diagnostic tests: European guidelines for clinical practice [corrected]. May 01, 2014
434 SOGC/CCMG, 2006 Carrier screening for genetic disorders in individuals of Ashkenazi Jewish descent. Apr 01, 2006
435 Spanish WG, 2014 Spanish guidelines for the management of autosomal dominant polycystic kidney disease. Sep 01, 2014
436 SSP, 2014 Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Apr 01, 2014
437 St Gallen, 2013 Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Sep 01, 2013
438 TES, 2008 Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. Dec 01, 2008
439 Thakker et al., 2012 Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). Sep 01, 2012
440 UK NEQAS, 2012 The UK NEQAS for Molecular Genetics scheme for gastrointestinal stromal tumour: findings and recommendations following four rounds of circulation. Sep 01, 2012
441 USPSTF, 2014 Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Feb 18, 2014
442 USPSTF, 2014 Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force. Feb 18, 2014
443 USPSTF, 2013 Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation Dec 01, 2013
444 USPSTF, 2013 Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Nov 19, 2013
445 USPSTF, 2012 Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Dec 18, 2012
446 USPSTF, 2009 Screening for sickle cell disease in newborns. Mar 15, 2009
447 USPSTF, 2008 Universal screening for hearing loss in newborns: US Preventive Services Task Force recommendation statement. Jul 01, 2008
448 USPSTF, 2008 Screening for Phenylketonuria (PKU): US Preventive Services Task Force Reaffirmation Recommendation: US Preventive Services Task Force Mar 01, 2008
449 USPSTF, 2006 Screening for hemochromatosis: recommendation statement. Aug 01, 2006
450 Vasen et al., 2007 Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) Jun 01, 2007
451 Vienna CCC-CNS, 2013 Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers. May 01, 2013
452 WFN, 1989 World Federation of Neurology: Research Committee. Research Group on Huntington's chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. Dec 01, 1989
453 WGO, 2013 World Gastroenterology Organisation global guidelines on celiac disease. Feb 01, 2013
454 Wood et al., 2012 Expert recommendations for the laboratory diagnosis of MPS VI. May 01, 2012
455 Yawn et al., 2014 Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Sep 10, 2014
456 Yoshida et al., 2011 Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. Nov 01, 2011

Support Center

Last updated: 2017-11-17T18:05:45Z